Effects of dexmedetomidine as an adjuvant to ropivacaine or ropivacaine alone on duration of postoperative analgesia: A systematic review and meta-analysis of randomized controlled trials
PLOS ONE · 2023
DOI: 10.1371/journal.pone.0287296 ↗Kurz gefasst
Metaanalyse in der Zeitschrift PLOS ONE, 2023. Verfasst von Fangzhou Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Guangxi Medical University Cancer Hospital, Nanning, Guangxi Zhuang Autonomous Region, China. Hauptthemen laut MEDLINE: Dexmedetomidine, Analgesia. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Ropivacaine is a long-acting local anesthetic that is used to treat postoperative pain. Adjuvant use of dexmedetomidine in regional anesthesia may prolong the duration of analgesia. The objective of this systematic review and meta-analysis was to investigate the duration and effect of ropivacaine alone vs. ropivacaine in combination with dexmedetomidine for postoperative analgesia.
Methods
The PubMed, EMBASE, Web of Science, and Google Scholar databases were searched for randomized controlled trials (RCTs) of ropivacaine alone or ropivacaine in combination with dexmedetomidine for regional anesthesia. The primary outcome was duration of analgesia, defined as the time from onset of the block to the time of the first analgesic request or initial pain report. Secondary outcomes were duration of sensory block, duration of motor block, consumption of sufentanil for analgesia, length of hospital stay, and incidence of postoperative nausea and vomiting.
Results
Eighteen studies with 1148 patients were included. Overall quality of the RCTs, as assessed by the Jadad scale, was high. The meta-analysis demonstrated that ropivacaine combined with dexmedetomidine significantly prolonged the duration of postoperative analgesia from local anesthetics compared to ropivacaine alone (WMD: 4.14h; 95%CI: 3.29~5.0h; P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, Guangxi Medical University Cancer Hospital, Nanning, Guangxi Zhuang Autonomous Region, China.
- Guangxi Key Laboratory for Basic Science and Prevention of Perioperative Organ Dysfunction, Nanning, Guangxi Zhuang Autonomous Region, China.
- Guangxi Engineering Research Center for Tissue & Organ Injury and Repair Medicine, Nanning, Guangxi Zhuang Autonomous Region, China.
- Guangxi Clinical Research Center for Anesthesiology, Nanning, Guangxi Zhuang Autonomous Region, China.
ORCID-Profile: Fangzhou Li, Linghui Pan
Zitieren
APA
Li, F., Guo, L., Huang, Z., Lin, F., & Pan, L. (2023). Effects of dexmedetomidine as an adjuvant to ropivacaine or ropivacaine alone on duration of postoperative analgesia: A systematic review and meta-analysis of randomized controlled trials. PLOS ONE. https://doi.org/10.1371/journal.pone.0287296
Vancouver
Li F, Guo L, Huang Z, Lin F, Pan L. Effects of dexmedetomidine as an adjuvant to ropivacaine or ropivacaine alone on duration of postoperative analgesia: A systematic review and meta-analysis of randomized controlled trials. PLOS ONE. 2023. doi:10.1371/journal.pone.0287296
BibTeX
@article{Li2023,
author = {Li, Fangzhou and Guo, Liang and Huang, Zijin and Lin, Fei and Pan, Linghui},
title = {Effects of dexmedetomidine as an adjuvant to ropivacaine or ropivacaine alone on duration of postoperative analgesia: A systematic review and meta-analysis of randomized controlled trials},
journal = {PLOS ONE},
year = {2023},
doi = {10.1371/journal.pone.0287296}
}
EUVIMED